Advertisement

Topics

Takeda Reports 1st Quarter 2016 Resultswith a Strong Start to the Year and Confidence in Management Guidance

07:41 EDT 30 Jul 2016 | Takeda

"Takeda had a strong start to FY2016, as we focus on executing our strategic roadmap. It is promising that our growth driver products are contributing strongly to each region's underlying revenue growth, especially ENTYVIO®, NINLARO®, ADCETRIS®, TRINTELLIX®, and TAKECAB®. Takeda

Original Article: Takeda Reports 1st Quarter 2016 Resultswith a Strong Start to the Year and Confidence in Management Guidance

NEXT ARTICLE

More From BioPortfolio on "Takeda Reports 1st Quarter 2016 Resultswith a Strong Start to the Year and Confidence in Management Guidance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...